PRUCALOPRIDE MEDTAS prucalopride (as succinate) 1 mg film-coated tablet blister pack

Ülke: Avustralya

Dil: İngilizce

Kaynak: Department of Health (Therapeutic Goods Administration)

Aktif bileşen:

prucalopride succinate, Quantity: 1.32 mg (Equivalent: prucalopride, Qty 1 mg)

Mevcut itibaren:

MedTAS Pty Ltd

Farmasötik formu:

Tablet, film coated

Kompozisyon:

Excipient Ingredients: lactose monohydrate; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; triacetin; macrogol 3000

Uygulama yolu:

Oral

Paketteki üniteler:

28 film-coated tablets

Reçete türü:

(S4) Prescription Only Medicine

Terapötik endikasyonlar:

Prucalopride is indicated for the treatment of chronic functional constipation in adults in whom laxatives fail to provide adequate relief. ? Before Prucalopride is considered patients must have tried at least two different types of laxatives from different classes (at the highest tolerated recommended doses) for at least six months, but have not had adequate relief from constipation. ? If treatment with Prucalopride is not effective within four weeks, the benefit of continuing treatment should be reconsidered.

Ürün özeti:

Visual Identification: White to off-white, round biconvex, film coated tablets debossed with P1 on one side and no debossing on the other side.; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Yetkilendirme durumu:

Registered

Yetkilendirme tarihi:

2022-09-12